These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27462126)

  • 1. MicroRNA Biomarkers of Toxicity in Biological Matrices.
    Harrill AH; McCullough SD; Wood CE; Kahle JJ; Chorley BN
    Toxicol Sci; 2016 Aug; 152(2):264-72. PubMed ID: 27462126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephron segment specific microRNA biomarkers of pre-clinical drug-induced renal toxicity: Opportunities and challenges.
    Nassirpour R; Ramaiah SK; Whiteley LO
    Toxicol Appl Pharmacol; 2016 Dec; 312():34-41. PubMed ID: 26827821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rat microRNA body atlas; Evaluation of the microRNA content of rat organs through deep sequencing and characterization of pancreas enriched miRNAs as biomarkers of pancreatic toxicity in the rat and dog.
    Smith A; Calley J; Mathur S; Qian HR; Wu H; Farmen M; Caiment F; Bushel PR; Li J; Fisher C; Kirby P; Koenig E; Hall DG; Watson DE
    BMC Genomics; 2016 Aug; 17(1):694. PubMed ID: 27576563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role for microRNAs in drug toxicity and in safety assessment.
    Marrone AK; Beland FA; Pogribny IP
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):601-11. PubMed ID: 25739314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
    Koenig EM; Fisher C; Bernard H; Wolenski FS; Gerrein J; Carsillo M; Gallacher M; Tse A; Peters R; Smith A; Meehan A; Tirrell S; Kirby P
    BMC Genomics; 2016 Aug; 17():649. PubMed ID: 27535741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as biomarkers for liver injury: Current knowledge, challenges and future prospects.
    Lin H; Ewing LE; Koturbash I; Gurley BJ; Miousse IR
    Food Chem Toxicol; 2017 Dec; 110():229-239. PubMed ID: 29042291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Promising Urinary MicroRNA Biomarkers in Two Rat Models of Glomerular Injury.
    Nassirpour R; Homer BL; Mathur S; Li Y; Li Z; Brown T; Carraher D; Warneke J; Bailey S; Percival K; O'Neil SP; Whiteley LO
    Toxicol Sci; 2015 Nov; 148(1):35-47. PubMed ID: 26253709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical Aspects Related to the Analysis of Circulating microRNAs.
    Butz H; Patócs A
    Exp Suppl; 2015; 106():55-71. PubMed ID: 26608199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological considerations for measuring biofluid-based microRNA biomarkers.
    Chorley BN; Atabakhsh E; Doran G; Gautier JC; Ellinger-Ziegelbauer H; Jackson D; Sharapova T; Yuen PST; Church RJ; Couttet P; Froetschl R; McDuffie J; Martinez V; Pande P; Peel L; Rafferty C; Simutis FJ; Harrill AH
    Crit Rev Toxicol; 2021 Mar; 51(3):264-282. PubMed ID: 34038674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNAs and their application in drug-induced liver injury.
    Wang Y; Chen T; Tong W
    Biomark Med; 2014; 8(2):161-72. PubMed ID: 24521012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating extracellular microRNA into clinical biomarkers for drug-induced toxicity: from high-throughput profiling to validation.
    Wang W; Shi Q; Mattes WB; Mendrick DL; Yang X
    Biomark Med; 2015; 9(11):1177-88. PubMed ID: 26501984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and regulatory application of microRNA biomarkers.
    Krauskopf J; Verheijen M; Kleinjans JC; de Kok TM; Caiment F
    Biomark Med; 2015; 9(11):1137-51. PubMed ID: 26502281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing sample and miRNA profile quality in serum and plasma or other biofluids.
    Blondal T; Jensby Nielsen S; Baker A; Andreasen D; Mouritzen P; Wrang Teilum M; Dahlsveen IK
    Methods; 2013 Jan; 59(1):S1-6. PubMed ID: 23036329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accessible miRNAs as Novel Toxicity Biomarkers.
    Bailey WJ; Glaab WE
    Int J Toxicol; 2018; 37(2):116-120. PubMed ID: 29357765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.
    Chaudhari U; Nemade H; Gaspar JA; Hescheler J; Hengstler JG; Sachinidis A
    Arch Toxicol; 2016 Dec; 90(12):3087-3098. PubMed ID: 26842497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs and drug-induced kidney injury.
    Pavkovic M; Vaidya VS
    Pharmacol Ther; 2016 Jul; 163():48-57. PubMed ID: 27126472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editor's Highlight: Plasma miR-183/96/182 Cluster and miR-124 are Promising Biomarkers of Rat Retinal Toxicity.
    Peng Q; Collette W; Giddabasappa A; David J; Twamley M; Kalabat D; Aguirre SA; Huang W
    Toxicol Sci; 2016 Aug; 152(2):273-83. PubMed ID: 27208084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of microRNA biomarker candidates in solid tissues and body fluids.
    Fehlmann T; Ludwig N; Backes C; Meese E; Keller A
    RNA Biol; 2016 Nov; 13(11):1084-1088. PubMed ID: 27687236
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.